Cargando…

MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism

BACKGROUND: Steroid cell tumor is a rare sex cord stromal tumor. There are 3 types including steroid cell tumor not otherwise specified (NOS), stromal luteoma and leydig cell tumors. Steroid cell tumor (NOS) is the most common of all the subtypes. About 75% of the steroid cell tumor (NOS) are secret...

Descripción completa

Detalles Bibliográficos
Autores principales: folawewo, kehinde Matilda, Shanaz, Fazeena, Hodge, MaKenzie, Osman, Nada, Zenebe, Anteneh Woldetensay, Ganta, Vijaya A, Odonkor, Wolali Akua-Sabia, Nunlee-Bland, Gail Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207934/
http://dx.doi.org/10.1210/jendso/bvaa046.1232
_version_ 1783530722304196608
author folawewo, kehinde Matilda
Shanaz, Fazeena
Hodge, MaKenzie
Osman, Nada
Zenebe, Anteneh Woldetensay
Ganta, Vijaya A
Odonkor, Wolali Akua-Sabia
Nunlee-Bland, Gail Louise
author_facet folawewo, kehinde Matilda
Shanaz, Fazeena
Hodge, MaKenzie
Osman, Nada
Zenebe, Anteneh Woldetensay
Ganta, Vijaya A
Odonkor, Wolali Akua-Sabia
Nunlee-Bland, Gail Louise
author_sort folawewo, kehinde Matilda
collection PubMed
description BACKGROUND: Steroid cell tumor is a rare sex cord stromal tumor. There are 3 types including steroid cell tumor not otherwise specified (NOS), stromal luteoma and leydig cell tumors. Steroid cell tumor (NOS) is the most common of all the subtypes. About 75% of the steroid cell tumor (NOS) are secretory. They can secrete androgens and estrogens. In a few cases, cortisol and renin secretion have been reported. The patient’s clinical features depend on the hormone secreted. CASE PRESENTATION Here, we report a case of a 22-year-old woman who was seen at an outpatient clinic for hirsutism, irregular menstrual bleeding, and progressive weight gain. Examination revealed androgenic facial hair growth, clitoromegaly and obesity. Initial differentials on presentation were PCOS, ovarian or adrenal pathology. Initial LH, FSH values were normal. Lab investigation showed elevated testosterone, DHEAS and 17-OH progesterone levels. Baseline labs showed Androstenedione of 3345 ng/dl (41-262 ng/dl), DHEAS of 595.5 ug/dl (110- 431.7 ug/dl), 17-OH progesterone was 2394 ng/dl (follicular: 15-70 ng/dl, Luteal: 35-290 ng/dl), total and free testosterone was 558 ng/dl (premenopausal; 10-55ng/dl) and 33.0 pg/ml, (0.8-1.4pg/ml), respectively. Patient subsequently had an ACTH stimulation test which showed an increase in 17-OH progesterone from 384 ng/dl to 657 ng/dl and a repeat showed an elevation from 204 to 322 ng/dl, ruling out a late onset CAH. She was then sent for pelvic sonogram which showed the presence of a left ovarian mass 4.9x 4.8x 4.8 cm and a pelvic CT scan confirmed a left ovarian mass measuring 6.8x5.5x 5.5 cm and an unremarkable right ovary. She underwent a laparoscopic unilateral salpino-oophorectomy and histology confirmed the diagnosis of an ovarian steroid cell tumor (NOS). Post-surgery, the androgen levels returned to normal. The patient is now being followed for recurrence. CONCLUSION Women who present with virilism should be evaluated adequately with comprehensive history taking and physical examination along with appropriate biochemical tests and imaging studies to confirm tumor location and plan for surgery.
format Online
Article
Text
id pubmed-7207934
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72079342020-05-13 MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism folawewo, kehinde Matilda Shanaz, Fazeena Hodge, MaKenzie Osman, Nada Zenebe, Anteneh Woldetensay Ganta, Vijaya A Odonkor, Wolali Akua-Sabia Nunlee-Bland, Gail Louise J Endocr Soc Reproductive Endocrinology BACKGROUND: Steroid cell tumor is a rare sex cord stromal tumor. There are 3 types including steroid cell tumor not otherwise specified (NOS), stromal luteoma and leydig cell tumors. Steroid cell tumor (NOS) is the most common of all the subtypes. About 75% of the steroid cell tumor (NOS) are secretory. They can secrete androgens and estrogens. In a few cases, cortisol and renin secretion have been reported. The patient’s clinical features depend on the hormone secreted. CASE PRESENTATION Here, we report a case of a 22-year-old woman who was seen at an outpatient clinic for hirsutism, irregular menstrual bleeding, and progressive weight gain. Examination revealed androgenic facial hair growth, clitoromegaly and obesity. Initial differentials on presentation were PCOS, ovarian or adrenal pathology. Initial LH, FSH values were normal. Lab investigation showed elevated testosterone, DHEAS and 17-OH progesterone levels. Baseline labs showed Androstenedione of 3345 ng/dl (41-262 ng/dl), DHEAS of 595.5 ug/dl (110- 431.7 ug/dl), 17-OH progesterone was 2394 ng/dl (follicular: 15-70 ng/dl, Luteal: 35-290 ng/dl), total and free testosterone was 558 ng/dl (premenopausal; 10-55ng/dl) and 33.0 pg/ml, (0.8-1.4pg/ml), respectively. Patient subsequently had an ACTH stimulation test which showed an increase in 17-OH progesterone from 384 ng/dl to 657 ng/dl and a repeat showed an elevation from 204 to 322 ng/dl, ruling out a late onset CAH. She was then sent for pelvic sonogram which showed the presence of a left ovarian mass 4.9x 4.8x 4.8 cm and a pelvic CT scan confirmed a left ovarian mass measuring 6.8x5.5x 5.5 cm and an unremarkable right ovary. She underwent a laparoscopic unilateral salpino-oophorectomy and histology confirmed the diagnosis of an ovarian steroid cell tumor (NOS). Post-surgery, the androgen levels returned to normal. The patient is now being followed for recurrence. CONCLUSION Women who present with virilism should be evaluated adequately with comprehensive history taking and physical examination along with appropriate biochemical tests and imaging studies to confirm tumor location and plan for surgery. Oxford University Press 2020-05-08 /pmc/articles/PMC7207934/ http://dx.doi.org/10.1210/jendso/bvaa046.1232 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reproductive Endocrinology
folawewo, kehinde Matilda
Shanaz, Fazeena
Hodge, MaKenzie
Osman, Nada
Zenebe, Anteneh Woldetensay
Ganta, Vijaya A
Odonkor, Wolali Akua-Sabia
Nunlee-Bland, Gail Louise
MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
title MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
title_full MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
title_fullStr MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
title_full_unstemmed MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
title_short MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
title_sort mon-024 steroid cell tumor, not otherwise specified; a rare case of hyperandrogenism
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207934/
http://dx.doi.org/10.1210/jendso/bvaa046.1232
work_keys_str_mv AT folawewokehindematilda mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism
AT shanazfazeena mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism
AT hodgemakenzie mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism
AT osmannada mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism
AT zenebeantenehwoldetensay mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism
AT gantavijayaa mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism
AT odonkorwolaliakuasabia mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism
AT nunleeblandgaillouise mon024steroidcelltumornototherwisespecifiedararecaseofhyperandrogenism